MaxCyte, Inc. (MXCT) Operating income 2019–2025
MaxCyte, Inc. (MXCT) annual operating income history from SEC filings — each fiscal year as reported.
-$51.9MFY2025 · since FY2019: -$12.4M → -$51.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$51.9M | -1.4% |
| FY2024 | -$51.2M | -6.0% |
| FY2023 | -$48.3M | -76.5% |
| FY2022 | -$27.4M | -50.4% |
| FY2021 | -$18.2M | -64.5% |
| FY2020 | -$11.1M | +11.0% |
| FY2019 | -$12.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice